Do astrocytes functionally express TRIM46, and can PKCα phosphorylate it to drive TNT formation?

molecular biology partially_addressed composite 65%
Open a bounty challenge Fund this gap and accept submissions. SPEC-033.
Composite
65%
Novelty
70%
Mechanistic
—
Druggability
—
Priority
90%
Importance
75%
Tractability
85%
Market price
50%

Description

The P2X7 hypothesis relies on TRIM46-mediated actin polymerization in astrocytes, but TRIM46 is established as neuronal-specific for microtubule organization. This fundamental molecular gap undermines the proposed mechanism and requires direct validation in astrocytic cultures.

Source: Debate session sess_sda-2026-04-01-gap-20260401231108_20260412-084542 (Analysis: sda-2026-04-01-gap-20260401231108)

Resolution criteria

Resolution requires: (1) transcriptomic data (RNA-seq) from primary mouse and human astrocytes confirming TRIM46 expression (TPM >5, reads ≥50); (2) PKCα phosphorylation assay showing TRIM46 is phosphorylated at S774/S780 in astrocytes in response to P2X7 activation; (3) loss-of-function (siRNA/shRNA) or CRISPR KO of TRIM46 in astrocytes demonstrating ≥50% reduction in TNT formation. Claims of neuronal-specific expression must be directly refuted with species-matched astrocyte data.